Document detail
ID

doi:10.1186/s12982-024-00168-z...

Author
Sahloff, Eric G. Sturgill, Kuan Vaidya, Varun Duggan, Joan M.
Langue
en
Editor

Springer

Category

Epidemiology

Year

2024

listing date

8/7/2024

Keywords
pharmacy hiv stigma safety single pharmacy spu ls multiple pharmacies hiv
Metrics

Abstract

Using multiple pharmacies has been linked to negative outcomes including increased inappropriate drug use, toxicity, and mortality, yet up to half of all patients in the US use multiple pharmacies.

A pilot survey was administered to measure pharmacy use in people living with HIV (PWH) and examine the associated attitudes and outcomes.

In a midwestern HIV clinic, a convenience sample was surveyed based on using single (SPU) versus multiple pharmacies (MPU).

One hundred forty-two subjects participated (69 SPU; 73 MPU): 75% male, 59% white, and > 70% being ≥ 40 years old.

There was a trend towards increased recall of self-reported CD4 and viral load status for SPUs vs MPUs [OR 2.26 (95%, 0.91–5.64)].

SPU participants indicated acquiring all meds in one place [Likert Scale weighted average (LS WA) = 4.45], proximity (LS WA = 3.64), the identification of adverse effects (LS WA = 4.17), and concerns about missing potential drug-drug interactions (LS WA = 4.06) as reasons for preferring a single pharmacy.

The desire to keep HIV status private (LS WA = 3.65) was noted as a significant reason for using a separate pharmacy specifically for acquiring antiretrovirals in MPU participants.

Results indicate patients often have justifiable reasons for using single versus multiple pharmacies.

Sahloff, Eric G.,Sturgill, Kuan,Vaidya, Varun,Duggan, Joan M., 2024, Use of multiple pharmacies by people living with HIV, Springer

Document

Open

Share

Source

Articles recommended by ES/IODE AI

High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation
bladder cancer pfk-1 zeb1 lactylation glycolysis inhibits lactate glucose bc pfk-1 cancer lactylation cells bladder